Pilot Evaluation of Citalopram for the Treatment of Hot Flashes in Women with Inadequate Benefit from Venlafaxine
- 1 October 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 8 (5) , 924-930
Abstract
Background: While newer antidepressants, such as venlafaxine and paroxetine, substantially decrease hot flashes, there is no published information with regards to whether a different antidepressant will be effective when one antidepressant does not adequately relieve hot flashes. Objective: The objective of this trial was to provide pilot information with regards to whether citalopram would effectively reduce hot flashes in patients who did not receive adequate enough hot flash reduction with venlafaxine. Design: This was a prospective pilot trial Measurements: Validated patient-completed hot flash diary questionnaires were utilized for measuring hot flashes. Subjects: Thirty patients were recruited to this trial, 22 of whom were fully evaluable. Results: Compared to a baseline week, hot flash scores were reduced by 53% 4 weeks later. The citalopram appeared to be well tolerated with many quality-of-life and potential toxicity symptoms much improved compared to the baseline week. At the end of the 4-week treatment, 19 patients (63% of patients entering the study and 86% of the patient completing the study treatment) chose to continue to use citalopram. Conclusion: This pilot information supports the hypothesis that citalopram will reduce hot flashes in patients with inadequate hot flash relief while taking venlafaxine.Keywords
This publication has 10 references indexed in Scilit:
- Paroxetine Controlled Release in the Treatment of Menopausal Hot FlashesJAMA, 2003
- Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trialObstetrics & Gynecology, 2003
- Depomedroxyprogesterone Acetate for Hot FlashesJournal of Pain and Symptom Management, 2002
- Pilot Evaluation of Gabapentin for Treating Hot FlashesMayo Clinic Proceedings, 2002
- Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized studyAnnals of Oncology, 2002
- Phase III Evaluation of Fluoxetine for Treatment of Hot FlashesJournal of Clinical Oncology, 2002
- Methodologic Lessons Learned From Hot Flash StudiesJournal of Clinical Oncology, 2001
- Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialThe Lancet, 2000
- Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.Journal of Clinical Oncology, 1998
- Megestrol Acetate for the Prevention of Hot FlashesNew England Journal of Medicine, 1994